Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathon C Arnold

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Frontiers in Physiology|May 25, 2023
Editorial: Cannabinoid interactions with ion channels, receptors, and the bio-membraneMohammad-Reza Ghovanloo, Jonathon C Arnold, Peter C Ruben
Expert Opinion on Therapeutic Targets|March 28, 2012
The therapeutic potential of the endocannabinoid system for Alzheimer's diseaseTim Karl, David Cheng, Brett Garner, et al.
European Journal of Pharmacology|July 16, 2008
Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1)Michelle L Holland, John D Allen, Jonathon C Arnold
Psychopharmacology|June 24, 2010
A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant miceLeonora E Long, Rose Chesworth, Jonathon C Arnold, et al.
Clinical and Translational Science|October 19, 2022
The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidenceJonathon C Arnold, Danielle McCartney, Anastasia Suraev, et al.
Drug and Alcohol Dependence Reports|September 15, 2025
Factors associated with cannabis use disorder among Australians using prescribed and illicitly-sourced medical cannabisLlewellyn Mills, Jonathon C Arnold, Iain S Mcgregor, et al.
Journal of Cannabis Research|October 28, 2025
Consumer perspectives of accessing medicinal cannabis treatment from cannabis clinics versus generalist health settings in AustraliaNicholas Lintzeris, Jonathon C Arnold, Iain S McGregor, et al.
Plos One|April 27, 2012
Enhanced brain disposition and effects of Δ9-tetrahydrocannabinol in P-glycoprotein and breast cancer resistance protein knockout miceAdena S Spiro, Alexander Wong, Aurélie A Boucher, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 14, 2016
Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophreniaDavid J Clarke, Jordyn Stuart, Iain S McGregor, et al.
Pharmacological Reports : PR|July 21, 2012
CB2 and TRPV1 receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cellsJonathon C Arnold, Phoebe Hone, Michelle L Holland, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Frontiers in Physiology|May 25, 2023
Editorial: Cannabinoid interactions with ion channels, receptors, and the bio-membraneMohammad-Reza Ghovanloo, Jonathon C Arnold, Peter C Ruben
Expert Opinion on Therapeutic Targets|March 28, 2012
The therapeutic potential of the endocannabinoid system for Alzheimer's diseaseTim Karl, David Cheng, Brett Garner, et al.
European Journal of Pharmacology|July 16, 2008
Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1)Michelle L Holland, John D Allen, Jonathon C Arnold
Psychopharmacology|June 24, 2010
A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant miceLeonora E Long, Rose Chesworth, Jonathon C Arnold, et al.
Clinical and Translational Science|October 19, 2022
The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidenceJonathon C Arnold, Danielle McCartney, Anastasia Suraev, et al.
Drug and Alcohol Dependence Reports|September 15, 2025
Factors associated with cannabis use disorder among Australians using prescribed and illicitly-sourced medical cannabisLlewellyn Mills, Jonathon C Arnold, Iain S Mcgregor, et al.
Journal of Cannabis Research|October 28, 2025
Consumer perspectives of accessing medicinal cannabis treatment from cannabis clinics versus generalist health settings in AustraliaNicholas Lintzeris, Jonathon C Arnold, Iain S McGregor, et al.
Plos One|April 27, 2012
Enhanced brain disposition and effects of Δ9-tetrahydrocannabinol in P-glycoprotein and breast cancer resistance protein knockout miceAdena S Spiro, Alexander Wong, Aurélie A Boucher, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 14, 2016
Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophreniaDavid J Clarke, Jordyn Stuart, Iain S McGregor, et al.
Pharmacological Reports : PR|July 21, 2012
CB2 and TRPV1 receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cellsJonathon C Arnold, Phoebe Hone, Michelle L Holland, et al.
Pageof 11